Home LiteratureArticle Details
PMID: 8538301 Published · ppublish English Journal Article Review

Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction?

Lancet (London, England) ·Vol. 347 ·No. 8994 ·1996-01-13 ·Pages 102-3

Massy ZA, Keane WF, Kasiske BL

Abstract

暂无摘要

MeSH Terms
Animals Cell Division/drug effects Cholesterol/metabolism Humans Hydroxymethylglutaryl CoA Reductases/pharmacology Hydroxymethylglutaryl-CoA Reductase Inhibitors In Vitro Techniques Mevalonic Acid/antagonists & inhibitors,metabolism
Chemicals
Hydroxymethylglutaryl-CoA Reductase Inhibitors Cholesterol Hydroxymethylglutaryl CoA Reductases Mevalonic Acid
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Massy Z A
Department of Medicine, Hennepin County Medical Center, South, Minneapolis, MN 55415, USA.
Keane W F
Kasiske B L
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
DOI
10.1016/s0140-6736(96)90217-2
Published
1996-01-13
Pages
102-3
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Corrections
CommentIn
PMID: 8596303
External Links
PubMed source DOI: 10.1016/s0140-6736(96)90217-2 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2